X

OCEA

Ocean Biomedical (OCEA) announces $134 million financial backing for innovative research and IND filings

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing…

Ocean Biomedical (OCEA) announces new findings in relation to treatment options for Hermansky-Pudlak Syndrome

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) announced its commitment to developing viable treatment options for Hermansky-Pudlak Syndrome (HPS) on…

Fundamental Research Corp. initiates coverage of Ocean Biomedical (OCEA) with “Buy” recommendation

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday said that Fundamental Research Corp. initiated equity analyst coverage of its stock with…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

The global pharmaceutical market is expected to cross $1.5 trillion this year, which represents a 4-5% annual growth over the…

Infographic: Ocean Biomedical Inc. (OCEA) quarter ended September 30, 2022

Ocean Biomedical, Inc. (NASDAQ: OCEA) was formed through the combination of Aesther Healthcare Acquisition Corp. with Ocean Biomedical. Here’s a look at…

Infographic: Ocean Biomedical Inc. (OCEA) quarter ended June 30, 2022

Ocean Biomedical, Inc. (NASDAQ: OCEA) was formed through the combination of Aesther Healthcare Acquisition Corp. with Ocean Biomedical. Here are the company’s…